Anxo Pharmaceutical Co., Ltd. (TPEX:6677)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.20
+0.15 (0.83%)
Apr 25, 2025, 1:39 PM CST

Anxo Pharmaceutical Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
358.92295.43241.32214.18207.76
Upgrade
Short-Term Investments
2.2389.75---
Upgrade
Cash & Short-Term Investments
361.14385.18241.32214.18207.76
Upgrade
Cash Growth
-6.24%59.61%12.67%3.09%16.96%
Upgrade
Accounts Receivable
210.5249.71240.86208.64191.06
Upgrade
Other Receivables
4.6711.3610.6310.4210.26
Upgrade
Receivables
215.17261.07251.49219.07201.32
Upgrade
Inventory
262.42283.86243.1238.88267.03
Upgrade
Prepaid Expenses
18.1522.1914.8817.1110.96
Upgrade
Other Current Assets
21.6925.9920.715.5417.61
Upgrade
Total Current Assets
878.56978.29771.5704.78704.69
Upgrade
Property, Plant & Equipment
1,0381,0791,1101,1401,152
Upgrade
Long-Term Investments
52.5630---
Upgrade
Goodwill
36.6136.6136.6136.6136.61
Upgrade
Other Intangible Assets
9.843.774.954.35.01
Upgrade
Long-Term Deferred Tax Assets
34.3822.0318.7511.777.45
Upgrade
Other Long-Term Assets
57.868.8232.7921.817.55
Upgrade
Total Assets
2,1082,2191,9741,9191,913
Upgrade
Accounts Payable
81.5579.6994.0378.4376.79
Upgrade
Accrued Expenses
88.4375.3571.5866.7373.94
Upgrade
Short-Term Debt
205215256.38215199.63
Upgrade
Current Portion of Long-Term Debt
63.4658.557.5564.6856.82
Upgrade
Current Portion of Leases
9.3614.6511.58.698.04
Upgrade
Current Income Taxes Payable
-6.686.764.332.09
Upgrade
Current Unearned Revenue
20.075.4314.475.0412.39
Upgrade
Other Current Liabilities
34.7631.4242.829.9536.17
Upgrade
Total Current Liabilities
502.61486.72555.07472.84465.87
Upgrade
Long-Term Debt
437.61480.7528.08572.61622.25
Upgrade
Long-Term Leases
11.21933.5721.492.35
Upgrade
Long-Term Unearned Revenue
16.2127.7326.4918.099.94
Upgrade
Other Long-Term Liabilities
0.581.191.262.021.34
Upgrade
Total Liabilities
968.211,0151,1441,0871,102
Upgrade
Common Stock
558.14556.64481.64481.64458.7
Upgrade
Additional Paid-In Capital
483.68478.85211.08206.62205.91
Upgrade
Retained Earnings
-25.4654.0132.1444.748.4
Upgrade
Comprehensive Income & Other
6----
Upgrade
Total Common Equity
1,0221,089724.86732.96713.02
Upgrade
Minority Interest
117113.76104.7898.9998.44
Upgrade
Shareholders' Equity
1,1391,203829.64831.94811.46
Upgrade
Total Liabilities & Equity
2,1082,2191,9741,9191,913
Upgrade
Total Debt
726.63787.84887.09882.47889.08
Upgrade
Net Cash (Debt)
-365.49-402.66-645.76-668.29-681.32
Upgrade
Net Cash Per Share
-6.56-7.81-13.41-13.78-14.18
Upgrade
Filing Date Shares Outstanding
55.8155.6648.1648.1648.16
Upgrade
Total Common Shares Outstanding
55.8155.6648.1648.1648.16
Upgrade
Working Capital
375.94491.57216.43231.93238.82
Upgrade
Book Value Per Share
18.3219.5715.0515.2214.80
Upgrade
Tangible Book Value
975.921,049683.3692.04671.4
Upgrade
Tangible Book Value Per Share
17.4918.8514.1914.3713.94
Upgrade
Land
576.53576.53576.53576.53576.53
Upgrade
Buildings
417.99417.99416.05417.89416.12
Upgrade
Machinery
463.03464.55434.6436.82410.26
Upgrade
Construction In Progress
9.88----
Upgrade
Leasehold Improvements
15.93.992.0210.099.03
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.